Cancer nanomedicines: oversold or underappreciated?

Expert Opin Drug Deliv. 2017 Jan;14(1):1-5. doi: 10.1080/17425247.2017.1262346. Epub 2016 Nov 28.
No abstract available

Keywords: Cancer nanomedicines; Clinical translation; Clinical trials; Combination treatment; Drug delivery; Drug targeting; EPR effect; Triggered release.

Publication types

  • Editorial